4/A: BiomX Inc. Director Susan Blum Corrects Error in Form 4 Filing Regarding Option Acquisition

Susan Blum, a director at BiomX Inc., filed an amended Form 4 to correct an error in reporting the acquisition of common stock options.

Summary

• Susan Blum, a director of BiomX Inc., filed an amendment to a previously filed Form 4.
• The amendment corrects an administrative error in Table II, Column 5 of the original filing.
• The error involved the reporting of the number of derivative securities acquired.
• The acquisition of 17,600 common stock options was incorrectly reported as a disposition (D) instead of an acquisition (A).
• No other changes were made to the originally filed Form 4.
• The options vest over four years, with 25% vesting on April 14, 2026, and the remainder vesting in 12 equal quarterly installments over three years.

Sentiment

Score: 7

Explanation: The document is a routine correction of a filing error, indicating standard corporate governance practices. There is no indication of positive or negative sentiment, but the correction itself is a positive sign of transparency.

Management Comments

• This amendment is being filed solely to correct an administrative error in Table II, Column 5.
• The number of derivative securities acquired was inadvertently reported under (D) of Column 5 instead of (A).
• No other changes have been made to the originally filed Form 4.

Industry Context

Form 4 filings are standard practice for company insiders (directors, officers, and 10% owners) to report transactions in their company's securities to the SEC, ensuring transparency and preventing insider trading.

Stakeholder Impact

• The correction ensures accurate information is available to shareholders and potential investors.

Key Dates

Keywords

Form 4, Amendment, BiomX Inc., Susan Blum, Stock Options, Acquisition, Director